BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14975242)

  • 41. STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P.
    Horiguchi A; Oya M; Marumo K; Murai M
    Kidney Int; 2002 Mar; 61(3):926-38. PubMed ID: 11849447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis.
    Panzer U; Schneider A; Guan Y; Reinking R; Zahner G; Harendza S; Wolf G; Thaiss F; Stahl RA
    Kidney Int; 2002 Aug; 62(2):455-64. PubMed ID: 12110006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
    Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
    FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
    Park EY; Cho IJ; Kim SG
    Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1.
    Fahmi H; Pelletier JP; Di Battista JA; Cheung HS; Fernandes JC; Martel-Pelletier J
    Osteoarthritis Cartilage; 2002 Feb; 10(2):100-8. PubMed ID: 11869069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1.
    Gao M; Hu Z; Zheng Y; Zeng Y; Shen X; Zhong D; He F
    Shock; 2011 Sep; 36(3):228-34. PubMed ID: 21617575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3.
    Wang LH; Yang XY; Mihalic K; Xiao W; Li D; Farrar WL
    J Biol Chem; 2001 Aug; 276(34):31839-44. PubMed ID: 11429412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association and contribution of ERK to IL-6-induced activation of signal transducer and activator of transcription in a human myeloma cell line.
    Song L; Shen B; Li Y
    Chin Med J (Engl); 2001 Sep; 114(9):954-7. PubMed ID: 11780390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional changes in rheumatoid fibroblast-like synovial cells through activation of peroxisome proliferator-activated receptor gamma-mediated signalling pathway.
    Yamasaki S; Nakashima T; Kawakami A; Miyashita T; Ida H; Migita K; Nakata K; Eguchi K
    Clin Exp Immunol; 2002 Aug; 129(2):379-84. PubMed ID: 12165097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas.
    Yu JH; Kim KH; Kim H
    Int J Biochem Cell Biol; 2008; 40(4):677-88. PubMed ID: 18035585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism.
    Davies GF; Khandelwal RL; Wu L; Juurlink BH; Roesler WJ
    Biochem Pharmacol; 2001 Oct; 62(8):1071-9. PubMed ID: 11597575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity.
    Yamakawa-Karakida N; Sugita K; Inukai T; Goi K; Nakamura M; Uno K; Sato H; Kagami K; Barker N; Nakazawa S
    Cell Death Differ; 2002 May; 9(5):513-26. PubMed ID: 11973610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
    Sinha D; Addya S; Murer E; Boden G
    Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
    Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
    Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
    Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
    Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein expression changes in the Sprague Dawley rat liver proteome following administration of peroxisome proliferator activated receptor alpha and gamma ligands.
    White IR; Man WJ; Bryant D; Bugelski P; Camilleri P; Cutler P; Hayes W; Holbrook JD; Kramer K; Lord PG; Wood J
    Proteomics; 2003 Apr; 3(4):505-12. PubMed ID: 12687617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
    Qiao L; Dai Y; Gu Q; Chan KW; Ma J; Lan HY; Zou B; Rocken C; Ebert MP; Wong BC
    Cancer Lett; 2008 Sep; 268(2):260-71. PubMed ID: 18477501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
    Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
    Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells.
    Garcia-Bates TM; Bernstein SH; Phipps RP
    Clin Cancer Res; 2008 Oct; 14(20):6414-25. PubMed ID: 18927280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.